>>> US Gapping up


Gapping up
In reaction to earnings/guidance:
  • DLO +30.5% (also names MELI exec as co-CEO, also momentum from Bloomberg report before close that co is considering a sale), CAVA +9.1%, LRN +8.1% (also announces content partnership with Doggyland), HRB +4.5% (also increases dividend by 10%), TJX +3.1%, HOLI +0.8%
Other news:
  • ANGO +9.4% (receives FDA breakthrough device designation for AngioVac System)
  • HHRS +7.3% (plans to redeem public warrants)
  • ANTX +5.6% (prices offering of 7,777,778 shares of its common stock at $9.00 per share)
  • NBTX +3.9% (expiration of HSR waiting period regarding the agreement for worldwide co-development and commercialization of potential first-in-class radioenhancer NBTXR3)
  • COIN +3.6% (secures approval to bring federally regulated crypto futures trading to eligible US customers)
  • AVAL +3.3% (Grupo Aval and Corporación Financiera Colombiana S.A. clarify misinformation circulating in the media)
  • NEXT +3.2% (stock offering by selling shareholders)
  • PBR +2.1% (says news re agreement with Federal Union is unfounded)
  • NVRO +1.9% (New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective Long-Term Relief from Painful Diabetic Neuropathy)
  • IDYA +1.8% (Announces First-Patient-In for Company-Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in (Neo)Adjuvant Uveal Melanoma)
  • ALHC +1.5% (CMO and COO Dr. Dinesh Kumar to depart)
  • ELP +1.4% (was notified that GQG Partners acquired a stake of 59,000,000 common shares)
  • REI +1.1% (completed its previously announced acquisition of the Central Basin Platform assets of Founders Oil & Gas IV)
Analyst comments:
  • MGNI +5.6% (upgraded to Outperform from In-line at Evercore ISI)
  • CTRE +1.8% (upgraded to Outperform from Market Perform at BMO Capital Markets)
  • GETY +1.6% (upgraded to Outperform from In-line at Imperial Capital)
  • SM +1.3% (upgraded to Overweight from Neutral at JP Morgan)
  • BRX +1.1% (upgraded to Buy from Neutral at Goldman)
  • PXD +1% (upgraded to Overweight from Neutral at JP Morgan)